first generic glp 1 New GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity Teva introduces first U.S. generic

Any new or concerning symptoms warrant medical review to distinguish between medication side effects, cannabis effects, or potential interactions

Zhou, Q., Verne, M

Some people with diabetes choose to use a tighter range of 70-140 mg/dl, though 70-180 is a good starting point for many

Meta-analyses of these and other studies have demonstrated: Reductions in total cholesterol typically in the range of 15% from baseline, varying by agent and population Decreases in LDL cholesterol ranging from 17%, generally more modest than dedicated lipid-lowering therapies Reductions in triglycerides of 515%, with greater effects often seen in those with higher baseline levels Variable effects on HDL cholesterol , with small increases (1-2%) or neutral effects reported The magnitude of lipid improvements appears to correlate with the degree of weight loss achieved, suggesting that metabolic benefits may be partially mediated through adiposity reduction

Karnes et al., 2014

Furthermore, an improvement in the MDS-UPDRS part 2 scores was observed